Polatuzumab vedotin-containing product in parenteral dose form 788331007
SNOMED CT code
SNOMED code | 788331007 |
---|---|
name | Polatuzumab vedotin-containing product in parenteral dose form |
status | active |
date introduced | 2020-01-31 |
fully specified name(s) | Product containing polatuzumab vedotin in parenteral dose form (medicinal product form) |
synonyms | Polatuzumab vedotin-containing product in parenteral dose form |
attributes - group1 | |
Has active ingredient | Polatuzumab vedotin 788328006 |
attributes - group0 | |
Has manufactured dose form | Parenteral dose form 385287007 |
Plays role | Antineoplastic therapeutic role 773879000 |
parents | |
children | Polatuzumab vedotin only product in parenteral dose form 788332000 |
hierarchies | a selection of possible paths SNOMED CT Concept 138875005Pharmaceutical / biologic product 373873005 Medicinal product 763158003 Product manufactured as parenteral dose form 440132002 Polatuzumab vedotin-containing product in parenteral dose form 788331007 SNOMED CT Concept 138875005 Pharmaceutical / biologic product 373873005 Medicinal product 763158003 Medicinal product categorized by therapeutic role 763087004 Antineoplastic agent 27867009 Monoclonal antibody antineoplastic agent 1144210000 Polatuzumab vedotin-containing product 788329003 Polatuzumab vedotin-containing product in parenteral dose form 788331007 |
ancestors | sorted most to least specific
|
cpt crosswalks |
Thank you for choosing Find-A-Code, please Sign In to remove ads.